Full Alliance Group Inc
OTC:FAGI
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.0052
0.11
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Full Alliance Group Inc
Full Alliance Group, Inc. is a holding company, which engages in technology, healthcare, and nutraceuticals. The company is headquartered in Palm Desert, California. The company went IPO on 2005-09-06. The Company’s subsidiary includes EBO2, Inc. EBO2, Inc. is the provider of EBO2, a blood treatment technology. EBO2 is a high-volume blood gas exchange unit for the treatment of 5-7 liters of blood with medical ozone, the unit allows extracorporeal blood and oxygenation and ozone exposure and blood filtration by using the integrated diffusing membranes within the filter fibers to trap lipids and proteins, which are in excess in the venous blood supply. EBO2 treatments and Nutra Yu nutraceutical products provides relief in cardiovascular disease, anxiety and depression, auto immune and inflammatory conditions, mold related issues, nutritional deficiencies, general health and wellness, lyme disease, gut health and digestive issues, cancer support, hormonal imbalances, chronic pain, and other.
Full Alliance Group, Inc. is a holding company, which engages in technology, healthcare, and nutraceuticals. The company is headquartered in Palm Desert, California. The company went IPO on 2005-09-06. The Company’s subsidiary includes EBO2, Inc. EBO2, Inc. is the provider of EBO2, a blood treatment technology. EBO2 is a high-volume blood gas exchange unit for the treatment of 5-7 liters of blood with medical ozone, the unit allows extracorporeal blood and oxygenation and ozone exposure and blood filtration by using the integrated diffusing membranes within the filter fibers to trap lipids and proteins, which are in excess in the venous blood supply. EBO2 treatments and Nutra Yu nutraceutical products provides relief in cardiovascular disease, anxiety and depression, auto immune and inflammatory conditions, mold related issues, nutritional deficiencies, general health and wellness, lyme disease, gut health and digestive issues, cancer support, hormonal imbalances, chronic pain, and other.
